SPC499
Efanesoctocog alfa eða lík líffræðileg lyfjaafurð í samræmi við Grein 10(4) í Skipun 2001/983/EC, eins og hún er vernduð af grunneinkaleyfinu / Efanesoctocog alfa or a similar biological medicinal product pursuant to Article 10(4) of Directive 2001/83/EC, as protected by the basic patent
Status:
UmsóknApplication date:
30.1.2025Application published:
15.2.2025
Medicine name:
AltuvoctMedicine for children:
No
Timeline
Today
30.1.2025Application
15.2.2025Publication
Marketing license
Foreign authorization number:
EU/1/24/1824Date:
17.6.2024
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, Waltham MA 02451 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP4176894